About Icon
ICON plc is a global contract research organization (CRO) based in Dublin, Ireland. Founded in 1990, the company has expanded to over 41,900 employees across more than 75 locations in over 40 countries. ICON specializes in consulting, outsourced development, and commercialization services for the pharmaceutical, biotechnology, medical device, government, and public health sectors. Its mission is to accelerate the development of drugs and medical devices that enhance quality of life.
The company offers a wide range of services throughout the product development lifecycle, including clinical development, functional outsourcing, laboratory services, and consulting. ICON also provides innovative solutions for decentralized and hybrid trials, medical imaging, and commercialization strategies. Its research spans various therapeutic areas, such as oncology, central nervous system disorders, vaccines, and more. ICON serves a diverse clientele, including pharmaceutical and biotechnology companies, medical device firms, and government organizations, helping them bring innovative therapies and devices to market efficiently.
The company offers a wide range of services throughout the product development lifecycle, including clinical development, functional outsourcing, laboratory services, and consulting. ICON also provides innovative solutions for decentralized and hybrid trials, medical imaging, and commercialization strategies. Its research spans various therapeutic areas, such as oncology, central nervous system disorders, vaccines, and more. ICON serves a diverse clientele, including pharmaceutical and biotechnology companies, medical device firms, and government organizations, helping them bring innovative therapies and devices to market efficiently.
No screenshot available